Á lódáil...
Development of an anti-human complement C6 monoclonal antibody that inhibits the assembly of membrane attack complexes
Membrane attack complexes (MACs; C5b-9) assembled after complement activation can directly injure self-tissues, leading to various diseases. Eculizumab, a monoclonal antibody (mAb) against complement component C5, is being used in the clinic to treat diseases in which MAC-mediated tissue damage is a...
Na minha lista:
| Foilsithe in: | Blood Adv |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
American Society of Hematology
2020
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7218433/ https://ncbi.nlm.nih.gov/pubmed/32396613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001690 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|